Literature DB >> 15781174

Constipation management in palliative care: a survey of practices in the United kingdom.

Margaret Goodman1, Joe Low, Susie Wilkinson.   

Abstract

Fifty percent of patients admitted to hospices cite constipation as a concern. This study evaluates how constipation was managed in 11 hospices. Patients and nurses completed questionnaires at two time points: baseline and 7-10 days later. Outcomes were evaluated using a Constipation Visual Analogue Scale and a satisfaction with management of constipation questionnaire. A total of 475 patients participated; 413 completed both assessments. Forty-six percent of patients reported no constipation and 15% of patients reported severe constipation. For 75% of patients, no change in the perception of constipation was observed over the study period. Patients expressed satisfaction with their constipation management. The severity of constipation was overestimated by nurses in many patients. The findings indicate that constipation was being prevented or reasonably well managed. However, severe constipation continues to be a problem. Assessment of patients' bowel function needs to be more rigorous and those identified as severely constipated need daily monitoring.

Entities:  

Mesh:

Year:  2005        PMID: 15781174     DOI: 10.1016/j.jpainsymman.2004.06.013

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  13 in total

1.  Clinical use of oral laxatives in palliative care services in Spain.

Authors:  Antonio Noguera; Carlos Centeno; Silvia Librada; María Nabal
Journal:  Support Care Cancer       Date:  2010-08-08       Impact factor: 3.603

2.  Concomitant Opioid and Laxative Use in Older Adults in Hospice Care in the United States: 2007.

Authors:  Denys T Lau; Lisa L Dwyer; Joseph W Shega
Journal:  J Am Geriatr Soc       Date:  2016-09-19       Impact factor: 5.562

3.  PEG vs. sennosides for opioid-induced constipation in cancer care.

Authors:  Philippa Hawley; Hannah MacKenzie; Monica Gobbo
Journal:  Support Care Cancer       Date:  2019-07-18       Impact factor: 3.603

4.  Constipation in specialized palliative care: factors related to constipation when applying different definitions.

Authors:  E Erichsén; A Milberg; T Jaarsma; M Friedrichsen
Journal:  Support Care Cancer       Date:  2015-07-10       Impact factor: 3.603

5.  A cross-sectional study of constipation and laxative use in advanced cancer patients: insights for revision of current practice.

Authors:  Chung Wah Cheng; Annie Ol Kwok; Zhao Xiang Bian; Doris Mw Tse
Journal:  Support Care Cancer       Date:  2012-06-01       Impact factor: 3.603

6.  A 73-year-old man with long-term immobility presenting with abdominal pain.

Authors:  Salomone Di Saverio; Gregorio Tugnoli; Paolo Emilio Orlandi; Marco Casali; Fausto Catena; Andrea Biscardi; Omeshnie Pillay; Franco Baldoni
Journal:  PLoS Med       Date:  2009-07-14       Impact factor: 11.069

7.  Managing opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide.

Authors:  Katri Elina Clemens; Eberhard Klaschik
Journal:  Ther Clin Risk Manag       Date:  2010-03-03       Impact factor: 2.423

8.  Self-reported constipation in patients with advanced cancer: a preliminary report.

Authors:  Wadih Rhondali; Linh Nguyen; Lynn Palmer; Duck-Hee Kang; David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2012-07-25       Impact factor: 3.612

Review 9.  Opioid-induced bowel dysfunction: pathophysiology and management.

Authors:  Christina Brock; Søren Schou Olesen; Anne Estrup Olesen; Jens Brøndum Frøkjaer; Trine Andresen; Asbjørn Mohr Drewes
Journal:  Drugs       Date:  2012-10-01       Impact factor: 9.546

Review 10.  Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.

Authors:  Roberto De Giorgio; Furio Massimino Zucco; Giuseppe Chiarioni; Sebastiano Mercadante; Enrico Stefano Corazziari; Augusto Caraceni; Patrizio Odetti; Raffaele Giusti; Franco Marinangeli; Carmine Pinto
Journal:  Adv Ther       Date:  2021-06-04       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.